Modulating the Alternative Pathway of the Complement System to Treat Inflammatory Diseases

Investors

Sanderling Ventures: Sanderling Ventures led the Series A financing of Taligen in August 2005 and has continued its participation in the Series B financing.

Alta Partners: Alta Partners co-led Taligen's Series B financing in January 2008 along with Clarus Ventures.

Clarus Ventures: Clarus Ventures co-led Taligen's Series B financing in January 2008 along with Alta Partners.

Tango/High County Venture: Tango/High Country Venture have participated in both Series A and Series B financings.